STIFEL FINANCIAL CORP

Position in TRVI — Trevi Therapeutics, Inc.

CIK 720672 ST. LOUIS, MO

Position in TRVI

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$468,151

+$161,528 QoQ

Shares Held

25,102

-2.3% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#136

of 216 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $537,727,692 across 104 Biotechnology names. TRVI ranks #65 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BHVN	Biohaven Ltd.	9,941,165	$147,924,534
2	VRTX	Vertex Pharmaceuticals Inc / Ma	162,151	$80,545,262
3	MANE	Veradermics, Inc	294,117	$36,158,743
4	JAZZ	Jazz Pharmaceuticals plc	139,491	$33,613,146
5	REGN	Regeneron Pharmaceuticals, Inc.	46,378	$28,918,535
6	OMER	Omeros Corp	1,836,925	$17,469,155
7	NTLA	Intellia Therapeutics, Inc.	1,014,387	$17,163,427
8	IONS	Ionis Pharmaceuticals Inc	202,983	$16,094,521

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$468,151	25,102	-2.3%	Shares	Defined	2026-08-12
2026-03-31	$306,623	25,702	-9.1%	Shares	Defined	2026-05-12
2025-12-31	$354,165	28,288	+23.5%	Shares	Defined	2026-02-13
2025-09-30	$209,543	22,901	+10.9%	Shares	Defined	2025-11-12
2025-06-30	$112,960	20,651	+50.6%	Shares	Defined	2025-08-14
2025-03-31	$86,266	13,715	+24.5%	Shares	Defined	2025-05-14
2024-12-31	$45,381	11,015	-2.6%	Shares	Defined	2025-02-13
2024-09-30	$37,785	11,313	-8.0%	Shares	Defined	2024-11-14
2024-06-30	$36,662	12,303	+21.8%	Shares	Defined	2024-08-13
2024-03-31	$34,855	10,103	+0.0%	Shares	Defined	2024-05-14
2023-12-31	$13,534	10,100	-27.0%	Shares	Defined	2024-02-12
2020-03-31	$45,550	13,845	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.